Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

The evolution of AI in clinical trials: from promise to practice

By David Kane

- PMLiVE

Medscape Online Continuing Medical Education Led to New Diagnoses in Alzheimer’s Disease

Medscape Education has recently published a study looking at the real-world impact of online continuing medical education on Alzheimer's disease diagnosis. Read the full article here.  The study, published in...

Medscape Education

- PMLiVE

Roche shares positive 96-week results for multiple sclerosis candidate fenebrutinib

The immune-mediated disease affects more than 2.9 million people worldwide

- PMLiVE

AstraZeneca receives CHMP recommendation for Imfinzi regimen in bladder cancer

More than 614,000 cases of bladder cancer are diagnosed globally every year

- PMLiVE

Sanofi and Stagecoach Performing Arts partner to highlight impact of autoimmune type 1 diabetes

Four adolescents with the condition have formed a girl band and released a song to empower patients

- PMLiVE

UKDRI researchers to evaluate new blood test for neurodegenerative disease diagnosis

It is hoped that the test could be available for widespread UK use in the coming years

- PMLiVE

In an era of deep uncertainty, life sciences companies require more than agile communications

By Tim Cockroft

- PMLiVE

Can we create a world where health is sustainable?

By Julia Crawford

Virtual Journal Clubs & Case Studies – Engaging Your Advisors Creatively

Creatively engage your advisors while deepening medical understanding! Dive into virtual journal clubs and case studies to analyze patient scenarios, dissect new research, and gain critical feedback on your brand...

Impetus Digital

Biogen Idec building

Biogen and City Therapeutics to develop RNAi therapies in deal worth over $1bn

The partners will focus on a target that mediates key central nervous system diseases

- PMLiVE

Sanofi gains access to Alzheimer’s candidate through $470m Vigil acquisition

A phase 2 trial of the drug is expected to launch in the third quarter of this year

- PMLiVE

The future of customer engagement in biopharma

By Aaron Bean

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links